Alithea Genomics SA

Alithea Genomics is a biotech company based in Epalinges, Switzerland, specializing in large-scale RNA sequencing. Founded in 2020 as an EPFL spin-off, the company develops technologies that enable rapid, low-cost analysis of gene expression, particularly to accelerate drug discovery, biomarker identification, and toxicology studies. Its approach relies notably on scalable transcriptomics solutions such as BRB-seq and DRUG-seq.